Register for email alerts and news feeds:
This journal | BMJ Group
rss
Heart 2005;91:131-132; doi:10.1136/hrt.2004.041756
Copyright © 2005 BMJ Publishing Group Ltd & British Cardiovascular Society
Heart 2005;91:131-132
© 2005 by BMJ Publishing Group & British Cardiac Society

EDITORIAL

Myocardial metabolic manipulation: a new therapeutic approach in heart failure?

E O’Meara, J J V McMurray

Department of Cardiology, Western Infirmary, Glasgow, UK

Correspondence to:
Correspondence to:
Professor John J V McMurray
Department of Cardiology, Western Infirmary, Glasgow, G11 6NT, UK; j.mcmurray{at}bio.gla.ac.uk

ABSTRACT

Myocardial metabolic manipulation using drugs such as trimetazidine may offer a new therapeutic approach to the treatment of heart failure

Abbreviations: ACE, angiotensin converting enzyme; ATP, adenosine triphosphate; FFT, free fatty acids; NYHA, New York Heart Association

Keywords: heart failure; myocardial metabolic manipulation; trimetazidine


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This article has been cited by other articles:

  • Zerumsky, K., McBride, B. F. (2006). Ranolazine in the management of chronic stable angina. Am J Health Syst Pharm 63: 2331-2338 [Abstract] [Full Text]  

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.